Author： Tönjes Anke Kovacs Peter
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.14, Iss.7, 2013-05, pp. : 825-833
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inhaled insulin beneficial in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. :
Access to resources
Recommend
ACE inhibitors: a `prudent' approach in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Mosapride: better glycaemic control in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. :
Benefits of better β-cell function with anakinra in type 2 diabetes?
Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. :
Inhaled insulin a viable alternative in type 1 diabetes?
Inpharma, Vol. 1, Iss. 1274, 2001-01 ,pp. :